Showing results (291-300 of 2,036) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|June 1, 1992
[Radioimmunoscintigraphy and magnetic resonance tomography in the diagnosis of urinary bladder cancer]P Benz, W Dewes, U Hau, et al.Nuklearmedizin. Nuclear Medicine|June 1, 1992
Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinomaE Bock, W Becker, J Scheele, et al.Nuklearmedizin. Nuclear Medicine|March 1, 1997
[123I-alpha-methyltyrosine scintigraphy in malignant melanoma]H Steinert, R Böni, R A Huch-Böni, et al.Nuklearmedizin. Nuclear Medicine|March 1, 1997
[A method for combined scatter and attenuation correction without transmission measurement for myocardial SPECT with 99m-Tc binding]J Kupferschläger, B Müller, G Schulz, et al.Nuklearmedizin. Nuclear Medicine|October 15, 1998
[Change of 99m technetium-pertechnetate uptake by the thyroid under suppression (TcTus) induced by optimization of iodine supply in Germany]M J Reinhardt, T Trupkovic, T Schumacher, et al.Nuklearmedizin. Nuclear Medicine|February 19, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?C Kobe, W Eschner, F Sudbrock, et al.Nuklearmedizin. Nuclear Medicine|February 19, 2008
Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imagingE Prager, M Wehrschuetz, B Bisail, et al.Nuklearmedizin. Nuclear Medicine|February 19, 2008
Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11F Füchtner, J Zessin, P Mäding, et al.Nuklearmedizin. Nuclear Medicine|May 22, 2008
[Demonstration of angiogenesis and the effect on an antiangiogenetic therapy with 99mTc labeled erythrocytes]P Zengel, C Bodenstein, R Senekowitsch-Schmidtke, et al.Nuklearmedizin. Nuclear Medicine|May 22, 2008
Factors affecting the specific activity of [18F]fluoride from a [18O]water targetF Füchtner, S Preusche, P Mäding, et al.Pageof 204